Table 4. .
Functional and Biochemical Markers of Performance and Recovery, Mean ± SD (95% Confidence Interval)
| Time |
|||||||
| Variable |
Pre-exercise |
Postexercise |
1 h |
24 h |
48 h |
72 h |
96 h |
| Maximum voluntary contraction, N·m | |||||||
| Placebo | 245.84 ± 25.94 (227.30, 264.40) | 187.31 ± 19.50 (173.40, 201.30) | 179.19 ± 20.41 (164.60, 193.80) | 167.54 ± 15.40 (156.50, 178.60) | 186.00 ± 17.35 (173.60, 198.40) | 207.19 ± 24.20 (189.90, 224.50) | 247.76 ± 27.15 (228.30, 267.20) |
| HPC | 252.31 ± 30.98 (230.10, 274.50) | 165.16 ± 17.62 (152.60, 177.80) | 162.87 ± 19.69 (148.80, 177.00) | 158.48 ± 18.80 (145.00, 171.90) | 178.23 ± 19.02 (164.60, 191.80) | 183.68 ± 21.64 (168.20, 199.20) | 227.89 ± 27.92 (207.90, 247.90) |
| LPC | 255.34 ± 26.91 (236.10, 274.60) | 206.54 ± 28.38a (186.20, 226.80) | 202.94 ± 24.11a (185.70, 220.20) | 212.01 ± 20.52a,b (197.30, 226.70) | 231.82 ± 24.11a,b (214.60, 249.10) | 256.51 ± 31.65a,b (233.90, 279.20) | 268.49 ± 30.85b (246.40, 290.60) |
| LPP | 248.62 ± 27.80 (228.70, 268.50) | 229.70 ± 26.97a,b (210.40, 249.00) | 235.77 ± 28.39a,b,c (215.50, 256.10) | 237.53 ± 25.30a,b (219.40, 255.60) | 252.00 ± 24.65a,b (234.40, 269.60) | 257.64 ± 28.39a,b (237.30, 277.90) | 282.38 ± 28.86a,b (261.70, 303.00) |
| Visual analogue scale, mm | |||||||
| Placebo | 0.00 ± 0.00 (0.00, 0.00) | 44.20 ± 12.47 (35.28, 53.12) | 43.40 ± 11.24 (35.36, 51.44) | 44.20 ± 13.13 (34.81, 53.59) | 37.80 ± 10.12 (30.56, 45.04) | 24.40 ± 11.04 (16.50, 32.30) | 14.40 ± 8.28 (8.48, 20.32) |
| HPC | 0.00 ± 0.00 (0.00, 0.00) | 42.10 ± 11.69 (33.74, 50.46) | 44.70 ± 12.86 (35.50, 53.90) | 45.30 ± 11.70 (36.93, 53.67) | 38.20 ± 9.46 (31.43, 44.97) | 25.30 ± 10.66 (17.67, 32.93) | 13.10 ± 9.43 (6.35, 19.85) |
| LPC | 0.00 ± 0.00 (0.00, 0.00) | 39.80 ± 11.66 (31.46, 48.14) | 41.40 ± 11.61 (33.09, 49.71) | 43.80 ± 12.16 (35.10, 52.50) | 36.40 ± 9.85 (29.35, 43.45) | 21.69 ± 10.40 (14.25, 29.13) | 15.60 ± 8.63 (9.43, 21.77) |
| LPP | 0.00 ± 0.00 (0.00, 0.00) | 40.20 ± 12.80 (31.04, 49.36) | 34.50 ± 10.72 (26.83, 42.17) | 22.90 ± 10.33a,b,c (15.51, 30.29) | 17.80 ± 8.55a,b,c (11.68, 23.92) | 9.30 ± 5.32a,b,c (5.49, 13.11) | 0.00 ± 0.00a,b,c (0.00, 0.00) |
| Creatine kinase, U·L– 1 | |||||||
| Placebo | 148.06 ± 32.12 (125.10, 171.00) | 256.30 ± 69.63 (206.50, 306.10) | 196.95 ± 6.56 (192.30, 201.60) | 234.85 ± 80.26 (177.40, 292.30) | 413.20 ± 77.36 (357.90, 468.50) | 230.35 ± 42.51 (199.90, 260.80) | 227.75 ± 57.21 (186.80, 268.70) |
| HPC | 138.30 ± 34.49 (113.60, 163.00) | 306.51 ± 76.41 (251.80, 361.20) | 273.62 ± 53.14b (235.60, 311.60) | 317.70 ± 87.65b (255.00, 380.40) | 410.18 ± 88.38 (347.00, 473.40) | 261.97 ± 89.53 (197.90, 326.00) | 227.08 ± 64.64 (180.80, 273.30) |
| LPC | 137.29 ± 17.04 (125.10, 149.50) | 246.28 ± 48.24 (211.80, 280.80) | 207.76 ± 49.58 (172.30, 243.20) | 185.97 ± 44.23a (154.30, 217.60) | 195.71 ± 33.84a,b (171.50, 219.90) | 207.47 ± 66.35 (160.00, 254.90) | 208.78 ± 46.94 (175.20, 242.40) |
| LPP | 153.23 ± 44.60 (121.30, 185.10) | 188.98 ± 48.72a (154.10, 223.80) | 154.35 ± 34.89a (129.40, 179.30) | 150.41 ± 39.76a,b (122.00, 178.90) | 136.84 ± 36.02a,b (111.10, 162.60) | 141.76 ± 46.02a,b (108.80, 174.70) | 157.69 ± 45.73a,b (125.00, 190.40) |
Abbreviations: HPC, high-powered continuous laser/light; LPC, low-powered continuous laser/light; LPP, low-powered pulsed laser/light.
a
Different from HPC (P < .05).
b
Different from placebo (P < .05).
c
Different from LPC (P < .05).